RESULTS: Low ALOX15B expression was associated with inferior progression-free survival (PFS), immunosuppressive microenvironment, and reduced CD8 + T cell cytotoxicity in DLBCL. The gene discussed is CD8A; the disease is diffuse large B-cell lymphoma.